News

Kenox Pharmaceuticals Welcomes Dr. Julianne Berry as Vice President of R&D and Manufacturing

Back

Princeton, NJ - Kenox Pharmaceuticals Inc. (Kenox) has appointed Dr. Julianne Berry as VP of R&D and Manufacturing to lead contract development, manufacturing, and testing across the company’s inhalation, intranasal, and ophthalmic pipeline. With 30+ years of end-to-end experience in branded and generic respiratory and specialty products, Dr. Berry has contributed to multiple marketed MDIs, nasal sprays, DPIs, and nebulizers. She previously held executive and leadership roles at Schering-Plough, Merck, Novel, Lupin, Glenmark, and Odin, and is recognized for significant contributions to respiratory drug delivery through publications, patents, and industry-consortium leadership.

“I am thrilled to join the highly experienced and creative Kenox team committed to accelerating the development of an innovative pipeline of inhaled, intranasal, and ophthalmic products. I’m excited to help bring these life-changing therapies to the clinic faster and more efficiently so patients can access them as quickly as possible.” — Dr. Julianne Berry

Read the full press release: Click here.